Results 91 to 100 of about 2,534,544 (260)
ABSTRACT Approximately 6%–8% of children and adolescents with rhabdomyosarcoma (RMS) have an underlying cancer predisposition disorder (CPD), which varies between embryonal and alveolar subtypes and other clinical characteristics. Identifying a CPD remains challenging, as traditional approaches rely on clinical features and family history. Additionally,
Taylor M. Luckie +12 more
wiley +1 more source
The role of hyperthermia in modern radiation treatment- state of art
The role of hyperthermia (HT) in conventional oncological treatment has been a subject of research for decades; however, HT has not been incorporated into treatment guidelines on a universal basis.
Aneta Borkowska +3 more
doaj +1 more source
Soft-Tissue Sarcoma of the left Thigh: case presentation [PDF]
Soft tissue sarcoma is a type of cancer that originates from mesenchymal tissue and typically displays symptoms in later stages. Undifferentiated pleomorphic sarcoma is a subtype of soft tissue sarcoma that can be found in any body part.
marouane dinia
core
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Trabectedin and its potential in the treatment of soft tissue sarcoma
Philippe A Cassier1, Armelle Dufresne1, Jean-Yves Blay1,2,3, Jérôme Fayette2,31Unité de Jour d’Oncologie Médicale Multidisciplinaire, Hôpital Edouard Herriot, Lyon, France; 2Dé ...
Philippe A Cassier +3 more
core
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin [PDF]
Contains fulltext : 170961.pdf (Publisher’s version ) (Open Access)Soft-tissue sarcomas (STS) are a heterogeneous group of rare solid tumors of mesenchymal origin.
Desar, I.M.E. +9 more
core +2 more sources
ABSTRACT Background Although MDM2 FISH test has been increasingly used to differentiate ALT and benign lipomatous tumours, its impact on clinical outcome remains underexplored. This study investigated whether routine MDM2 FISH testing on preoperative biopsy is associated with a reduction in the recurrence risk of ALT.
Samuel O. H. Ching +5 more
wiley +1 more source
Geoffrey W Siegel,1 J Sybil Biermann,1 Rashmi Chugh,2 Jon A Jacobson,3 David Lucas,4 Mary Feng,5 Andrew C Chang,6 Sean R Smith,7 Sandra Wong,6 Jill L Hasen1 1Department of Orthopedics, 2Department of Medical Oncology, 3Department of Radiology ...
Lucas D +9 more
core
ABSTRACT Background Text‐based pathology reports inadequately communicate complex three‐dimensional (3D) relationships in musculoskeletal oncology, potentially contributing to errors in re‐resection and adjuvant treatment planning. While our prior 7‐case pilot study established technical feasibility, the scalability of this workflow and its utility as ...
Riley S. Gilbertson +11 more
wiley +1 more source
ABSTRACT Introduction Sarcomas are rare malignancies that affect both adults and children. Surgical removal with negative histopathological margins is the foundation of sarcoma treatment. Failure to achieve negative margins puts patients at risk of local recurrence (LR). LR rates range between 10% and 30%.
Sumail Bhogal +13 more
wiley +1 more source

